These results approach what weekly semaglutide achieved, validating the monthly concept
The GLP-1 analogue market is a pharmaceutical phenomenon, projected to surge from $45.3 billion in 2025 to a staggering $122.3 billion by 2030
While GLP-1 jabs have been shown in randomised controlled trials lead to weight loss of 15 to 20%, around half of all patients discontinue their use within the first year, with three-quarters stopping after two years
Instead, they contain ingredients that they claim help your body produce GLP-1 naturally, such as caffeine, berberine, and other herbal extracts
What GLP-1 Medications Actually Do in the Body GLP-1 receptor agonists like semaglutide and tirzepatide work primarily by mimicking a gut hormone that regulates appetite and blood sugar
10.1093/ckj/sfac274 [DOI] [PMC free article] [PubMed] [Google Scholar] 29